ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Genaissance Pharmaceuticals (MM)

Genaissance Pharmaceuticals (MM) (GNSC)

0,00
0,00
(0,00%)
Fermé 05 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
-
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
-
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

GNSC Dernières nouvelles

Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo

NEW HAVEN, Conn. and TOKYO, Oct. 3 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into an agreement with Sankyo, Co., Ltd...

Genaissance Enters Pharmacogenomic Collaboration with Otsuka

NEW HAVEN, Conn. and TOKYO, Sept. 21 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered into a pharmacogenomic research collaboration...

Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements

NEW HAVEN, Conn., and MARSEILLE, France, Sept. 12 /PRNewswire-FirstCall/ -- Privately-held Ipsogen SAS and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that they have signed...

Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract

- Increases Presence in EU Ag Genotyping Market - NEW HAVEN, Conn., Aug. 23 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced today that it will provide its...

Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract

- Will Address EU Mandate for Sheep-Breeding Programs That Confer Resistance to Scrapie - NEW HAVEN, Conn., Aug. 11 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC...

Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon

Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon NEW HAVEN, Conn. and OSS, Netherlands, July 18 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals...

Clinical Data to Acquire Genaissance Pharmaceuticals

Clinical Data to Acquire Genaissance Pharmaceuticals Combined Company to Deliver Industry-Defining Theranostics NEWTON, Mass., and NEW HAVEN, Conn., June 21 /PRNewswire-FirstCall/ -- Clinical...

Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics

Clinical Data, Inc. (NASDAQ:CLDA) and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that they have signed an agreement for Clinical Data to acquire Genaissance Pharmaceuticals in...

Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner

Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner NEW HAVEN, Conn., June 7 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) announced...

Genaissance Reports First Quarter 2005 Results

Genaissance Reports First Quarter 2005 Results Company Cites Progress In Key Areas, Including Recent Increase In Cash Reserves NEW HAVEN, Conn., May 3 /PRNewswire-FirstCall/ -- Genaissance...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GNSC - Frequently Asked Questions (FAQ)

What is the current Genaissance share price?
The current share price of Genaissance is US$ 0,00
What is the 1 year trading range for Genaissance share price?
Genaissance has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CAPTCaptiVision Inc
US$ 1,024
(133,26%)
246M
QNTMQuantum Biopharma Ltd
US$ 6,70
(110,69%)
78,56M
LTRYLottery com Inc
US$ 0,58
(85,90%)
129,21M
CPIXCumberland Pharmaceutical Inc
US$ 3,7801
(77,47%)
18,49M
INKTMiNK Therapeutics Inc
US$ 12,08
(53,69%)
350,86k
OMGAOmega Therapeutics Inc
US$ 0,1473
(-69,25%)
11,71M
VIRXViracta Therapeutics Inc
US$ 0,0352
(-54,76%)
6,33M
CYNCYNGN Inc
US$ 0,0708
(-39,44%)
137,42M
UPCUniverse Pharmaceuticals Inc
US$ 0,2663
(-36,20%)
1,9M
CSAICloudastructure Inc
US$ 12,98
(-31,68%)
57,03k
NVDANVIDIA Corporation
US$ 118,65
(1,71%)
247,88M
CAPTCaptiVision Inc
US$ 1,024
(133,26%)
245,99M
PLTRPalantir Technologies Inc
US$ 103,83
(23,99%)
212,8M
RGTIRigetti Computing Inc
US$ 13,71
(1,78%)
150,63M
CYNCYNGN Inc
US$ 0,0708
(-39,44%)
134,64M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock